Wave Life Sciences (NASDAQ:WVE) shares soared 66% Wednesday morning after the company announced positive proof-of-mechanism ...
Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...
GSK said that its urinary tract infections treatment gepotidacin has been accepted for priority review by the U.S.'s Food and Drug Administration.